CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome

BACKGROUND: Approximately 5% to 10% of pancreatic ductal adenocarcinoma (PDAC) has a hereditary basis. In most of these defined hereditary cancer syndromes, PDAC is not the predominant cancer type. Traditional criteria for publicly funded genetic testing typically require the presence of a set combi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hered Cancer Clin Pract
Autores principales: Cremin, Carol, Howard, Sarah, Le, Lyly, Karsan, Aly, Schaeffer, David F., Renouf, Daniel, Schrader, Kasmintan A.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842519/
https://ncbi.nlm.nih.gov/pubmed/29541281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-018-0088-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares